Pasquale Maria E's Form 4 filing
Incyte Corp (INCY) · filed Feb 2, 2023
- Accession no.
- 0001209191-23-006174
- Filed
- Feb 2, 2023
- Trade date
- Jan 31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $67.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pasquale Maria ECIK 0001736295 | Officer (EVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Common Stock | MOption exerciseAcquired | +802 | $74.78 | +$59,973.56 | 69,326 | Direct | |
| Jan 31, 2023 | Common Stock | SSaleDisposed | −802 | $84.06F1 | −$67,416.12 | 68,524 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Common Stock | MOption exerciseDisposed | −802 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Referenced by the price of 1 transaction in Table I.